The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


Published online July 10, 2009
The Journal of Immunology, 2009, 183, 1797 -1803
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0800672

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
jimmunol.0800672v1
183/3/1797    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Chen, M.-C.
Right arrow Articles by Lin, Y.-S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, M.-C.
Right arrow Articles by Lin, Y.-S.

Deletion of the C-Terminal Region of Dengue Virus Nonstructural Protein 1 (NS1) Abolishes Anti-NS1-Mediated Platelet Dysfunction and Bleeding Tendency1

Mei-Chun Chen*, Chiou-Feng Lin{dagger}, Huan-Yao Lei*, Shih-Chao Lin*, Hsiao-Sheng Liu*, Trai-Ming Yeh{ddagger}, Robert Anderson and Yee-Shin Lin2,*,§

* Department of Microbiology and Immunology, {dagger} Institute of Clinical Medicine, {ddagger} Department of Medical Laboratory Science and Biotechnology, and § Center for Gene Regulation and Signal Transduction Research, National Cheng Kung University Medical College, Tainan, Taiwan; and Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada

The mechanisms underlying dengue hemorrhagic disease are incompletely understood. We previously showed that anti-dengue virus (DV) nonstructural protein 1 (NS1) Abs cross-react with human platelets and inhibit platelet aggregation. Based on sequence homology alignment, the cross-reactive epitopes reside in the C-terminal region of DV NS1. In this study, we compared the effects of Abs against full-length DV NS1 and NS1 lacking the C-terminal aa 271 to 352 (designated {Delta}C NS1). Anti-{Delta}C NS1 Abs exhibited lower platelet binding activity than that of anti-full-length NS1. Anti-full-length NS1 but not anti-{Delta}C NS1 Abs inhibited platelet aggregation, which was shown to involve integrin {alpha}IIbβ3 inactivation. We found that the bleeding time in full-length NS1-hyperimmunized mice was longer than that in the normal control mice. By contrast, {Delta}C NS1-hyperimmunized mice showed a bleeding time similar to that of normal control mice. Passively administered anti-DV NS1, but not anti-{Delta}C NS1, Ab level decreased markedly in serum and this decrease was correlated with Ab binding to platelets. A transient platelet loss in the circulation was observed after anti-DV NS1, but not anti-{Delta}C NS1, Ab administration. In summary, platelet dysfunction and bleeding tendency are induced by anti-full-length DV NS1 but not by anti-{Delta}C NS1 Abs. These findings may be important not only for understanding dengue hemorrhagic disease pathogenesis but also for dengue vaccine development.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Grant NSC95–3112-B006–002 from the National Research Program for Genomic Medicine, National Science Council, Taiwan.

2 Address correspondence and reprint requests to Dr. Yee-Shin Lin, Department of Microbiology and Immunology, National Cheng Kung University Medical College, 1 University Road, Tainan 701, Taiwan. E-mail address: yslin1{at}mail.ncku.edu.tw

3 Abbreviations used in this paper: DV, dengue virus; DHF, dengue hemorrhagic fever; DSS, dengue shock syndrome; NS1, nonstructural protein 1; JEV, Japanese encephalitis virus; PF-4, platelet factor-4; PDI, protein disulfide isomerase.

4 The online version of this article contains supplemental material.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.